VivoSim Labs (VIVS) EBT Margin Growth (3y) (2014 - 2026)
Powered by 
Analysis
VivoSim Labs (VIVS) EBT Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -317.00 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 501.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -173.00 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -684.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -522.00 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -6,872.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 1,748.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -8.87 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -981,044.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -981,044.00 |
| Mar 31, 2026 | -319,491.00 |
| Dec 31, 2025 | -789,504.00 |
| Sep 30, 2025 | -486,006.00 |
| Mar 31, 2025 | -604,515.00 |
| Dec 31, 2022 | -74,120.00 |
| Sep 30, 2022 | -368,192.00 |
| Mar 31, 2022 | 89,951.00 |
| Dec 31, 2019 | -88,135.00 |
| Sep 30, 2019 | 14,603.00 |
| Jun 30, 2019 | 3,421.00 |
| Mar 31, 2019 | 50,265.00 |
| Dec 31, 2018 | 237,502.00 |
| Sep 30, 2018 | 312,388.00 |
| Jun 30, 2018 | 168,622.00 |
| Mar 31, 2018 | 230,806.00 |
| Dec 31, 2017 | 381,009.00 |
| Sep 30, 2017 | 333,285.00 |
| Jun 30, 2017 | 544,727.00 |
| Sep 30, 2016 | 655,567.00 |